Allan Jonathan sold STOK

October 3, 2025 · Form 4 insider transaction

Allan Jonathan sold 10,000 shares of Stoke Therapeutics, Inc. at $25.07 per share, a transaction worth $250.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
10,000
Price
$25.07
Total value
$250.7K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after11,831
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR